Innovative therapeutics

Investors

IR Snapshot

NASDAQBMRN
Beta0.73
Shares Outstanding181.3M
Average Volume (10 days)1.2M
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$0.67
Sales (TTM)$7.64
Book Value (MRQ)$17.85
Cash Flow (TTM)$0.77
Cash (MRQ)$7.64

Analyst Views

Current Mean RecommendationBuy
Strong Buy11
 
Buy0
 
Hold8
 
Underperform0
 
Sell0
 

Recent Insider Transactions

David E.I. Pyott
Director
11,900
Buy
Aug 31, 2020
David E.I. Pyott
Director
900
Buy
Aug 31, 2020
Michael G. Grey
Director
(2,500)
Sell
Aug 3, 2020
Michael G. Grey
(2,500)
Sell
Aug 3, 2020
Henry J. Fuchs
President, Worldwide R&D
(126,389)
Sell
Jul 20, 2020

Recent SEC Filings

Insider Buy/Sell
Oct 15, 2020
Insider Buy/Sell
Oct 8, 2020
Amended >= 5% Acquisition
Sep 10, 2020
Company Events
Sep 9, 2020
Insider Buy/Sell
Sep 1, 2020

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information